鼻腔菌群多样性与慢性鼻窦炎伴鼻息肉手术预后相关性分析

杨凤娟, 甘卫刚, 刘锋, 等. 鼻腔菌群多样性与慢性鼻窦炎伴鼻息肉手术预后相关性分析[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(9): 799-804. doi: 10.13201/j.issn.2096-7993.2020.09.008
引用本文: 杨凤娟, 甘卫刚, 刘锋, 等. 鼻腔菌群多样性与慢性鼻窦炎伴鼻息肉手术预后相关性分析[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(9): 799-804. doi: 10.13201/j.issn.2096-7993.2020.09.008
YANG Fengjuan, GAN Weigang, LIU Feng, et al. The correlation between nasal bacterial microbiome diversity and surgical prognosis for chronic sinusitis with nasal polyp[J]. J Clin Otorhinolaryngol Head Neck Surg, 2020, 34(9): 799-804. doi: 10.13201/j.issn.2096-7993.2020.09.008
Citation: YANG Fengjuan, GAN Weigang, LIU Feng, et al. The correlation between nasal bacterial microbiome diversity and surgical prognosis for chronic sinusitis with nasal polyp[J]. J Clin Otorhinolaryngol Head Neck Surg, 2020, 34(9): 799-804. doi: 10.13201/j.issn.2096-7993.2020.09.008

鼻腔菌群多样性与慢性鼻窦炎伴鼻息肉手术预后相关性分析

  • 基金项目:
    国家自然科学基金(No:81570900);四川省科技厅国际合作项目(No:2018HH0097)
详细信息

The correlation between nasal bacterial microbiome diversity and surgical prognosis for chronic sinusitis with nasal polyp

More Information
  • 目的 比较慢性鼻窦炎伴鼻息肉(CRSwNP)术后复发与非复发患者鼻腔菌群多样性的差异,为CRSwNP治疗及预后判断提供新思路和依据。方法 纳入48例CRSwNP为实验组以及33例具有FESS手术指征且未合并鼻窦炎症疾病的鼻中隔偏曲、鼻腔鼻窦内翻乳头状瘤、垂体腺瘤、慢性泪囊炎、视神经管骨折等患者为对照组,采用16S rRNA高通量测序法对术中采集的中鼻道分泌物进行菌群检测,比较CRSwNP术前与对照组间的菌群差异。CRSwNP患者术后进行1年随访,观察是否复发,并再次采集中鼻道分泌物进行菌群检测,分别比较CRSwNP非复发组与复发组术后菌群与术前菌群的差异。结果 术后1年内,12例CRSwNP复发,复发率25%。复发组病史长于非复发组(P=0.018),且复发组术前CT评分(P=0.001)、鼻息肉大小评分(P=0.004)以及鼻后滴漏症状严重程度(P=0.032)明显高于非复发组。CRSwNP术前与对照组菌群丰富度、α多样性、β多样性比较差异无统计学意义,但放线菌门(FDR P=0.004)以及棒状杆菌属(FDR P=0.005)相对丰度(MRA)较对照组明显降低。非复发组患者术后放线菌门(FDR P=0.012)以及棒状杆菌属(FDR P=0.003) MRA较术前增高,拟杆菌门(FDR P=0.040) MRA较术前降低;而复发组术前、术后鼻腔菌群无明显变化。结论 CRSwNP与鼻腔菌群失调有关,且术后菌群失调是否改善与CRSwNP预后有相关性。
  • 加载中
  • 图 1  术前CRSwNP组与对照组鼻腔菌群PCoA分析

    图 2  非复发组术前与术后菌群细菌门水平比较

    图 3  非复发组术前与术后菌群细菌属水平比较

    表 1  复发组与非复发组CRSwNP术前临床特征比较 M(Q25Q75)

    项目 非复发组(n=36) 复发组(n=12) χ2/Z P
    病史/年 1.50(0.50~8.75) 6.50(0.30~10.00) 2.368 0.018
    CT评分/分 10.50(5.25~19.75) 22.50(14.00~24.00) 3.435 0.001
    Davos评分/分 2.00(1.25~4.00) 4.00(3.00~5.00) 2.912 0.004
    鼻部症状严重程度评分/分 5.90(4.00~7.45) 5.55(4.20~6.20) 0.095 0.924
    鼻阻评分/分 3.68(6.40~7.78) 7.05(6.50~9.00) 0.858 0.391
    头痛评分/分 0.80(0.00~3.38) 0.70(0.00~3.00) 0.219 0.827
    流涕评分/分 4.80(1.70~7.00) 6.25(3.90~9.10) 1.359 0.174
    鼻后滴漏评分/分 2.35(0.00~5.08) 6.10(2.50~8.00) 2.146 0.032
    嗅觉减退评分/分 4.85(0.00~8.88) 8.45(1.00~9.10) 0.891 0.373
    外周血嗜酸粒细胞计数/(×109·L-1) 0.22(0.11~0.39) 0.06(0.05~0.85) 1.383 0.167
    下载: 导出CSV

    表 2  CRSwNP组与对照组术前鼻腔菌群α多样性比较 x±s

    项目 CRSwNP组
    (n=48)
    对照组
    (n=33)
    P
    Sobs指数 463.750±
    484.540
    674.210± 506.270 0.082
    Shannon指数 2.415±1.415 2.606±1.436 0.581
    Simpson指数 0.307±0.236 0.280±0.227 0.638
    下载: 导出CSV

    表 3  术前CRSwNP组与对照组鼻腔菌群门水平MRA比较 %,x±s

    项目 CRSwNP组(n=48) 对照组(n=33) P FDR P
    厚壁菌门 53.700±33.720 42.050±26.930 0.180 0.377
    放线菌门 10.600±13.980 29.820±24.570 <0.001 0.004
    变形菌门 17.970±26.970 19.400±21.250 0.115 0.287
    拟杆菌门 10.120±14.310 3.090±4.311 0.101 0.287
    梭杆菌门 2.595±9.488 0.130±0.162 0.054 0.287
    酸杆菌门 0.243±0.601 1.040±2.967 0.118 0.287
    绿弯菌门 0.505±1.745 0.491±1.099 0.107 0.287
    蓝藻菌门 0.477±0.962 0.439±1.014 0.134 0.293
    疣微菌门 0.412±1.200 0.448±0.966 0.888 0.992
    下载: 导出CSV

    表 4  术前CRSwNP组与对照组鼻腔菌群属水平MRA比较 %,x±s

    项目 CRSwNP组(n=48) 对照组(n=33) P FDR P
    葡萄球菌属 10.370±22.580 16.390±24.150 0.003 0.307
    棒状杆菌属 5.408±11.060 21.270±23.340 <0.001 0.005
    乳酸菌属 20.120±31.540 4.809±17.050 0.018 0.461
    链球菌属 6.748±17.040 4.824±15.150 0.342 0.646
    狡诈菌属 0.573±2.207 7.373±13.990 0.001 0.307
    莫拉克斯菌属 1.602±9.820 5.451±18.580 0.031 0.502
    拟杆菌属 3.034±6.349 1.267±2.537 0.928 0.956
    埃希-志贺菌属 1.226±3.674 2.944±6.140 0.529 0.734
    嗜血杆菌属 3.676±15.480 0.141±0.313 0.037 0.502
    假单胞菌属 2.187±13.520 1.370±6.821 0.009 0.375
    罗尔斯通菌属 1.651±6.192 1.413±3.414 0.604 0.804
    红球菌属 1.627±4.097 0.941±1.173 0.381 0.646
    未分类肠杆菌 1.232±7.112 1.304±6.631 0.123 0.537
    奈瑟菌属 2.130±13.690 0.336±1.398 0.021 0.461
    梭杆菌属 1.747±7.303 0.087±0.115 0.065 0.537
    肠球菌属 0.158±0.653 1.411±7.723 0.743 0.894
    卟啉单胞菌属 1.325±5.648 0.034±0.095 0.056 0.526
    下载: 导出CSV
  • [1]

    Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe—an underestimated disease. A GA2LEN study[J]. Allergy, 2011, 66(9): 1216-1223. doi: 10.1111/j.1398-9995.2011.02646.x

    [2]

    Hirsch AG, Stewart WF, Sundaresan AS, et al. Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample[J]. Allergy, 2017, 72(2): 274-281. doi: 10.1111/all.13042

    [3]

    Shi JB, Fu QL, Zhang H, et al. Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities[J]. Allergy, 2015, 70(5): 533-539. doi: 10.1111/all.12577

    [4]

    李宏梅, 薛金梅. 金黄色葡萄球菌在难治性鼻-鼻窦炎发病机制中的作用[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(5): 404-408. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201705020.htm

    [5]

    Ba L, Zhang N, Meng J, et al. The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polyps[J]. Allergy, 2011, 66(10): 1296-1303. doi: 10.1111/j.1398-9995.2011.02637.x

    [6]

    Gan W, Yang F, Tang Y, et al. The difference in nasal bacterial microbiome diversity between chronic rhinosinusitis patients with polyps and a control population[J]. Int Forum Allergy Rhinol, 2019, 9(6): 582-592. doi: 10.1002/alr.22297

    [7]

    Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012[J]. Rhinol Suppl, 2012, 23: 3 p preceding table of contents, 1-298.

    [8]

    Meng YF, Lou HF, Wang CS, et al. [The value of sinonasal CT scan in diagnosing of eosinophilic chronic rhinosinusitis with nasal polyps] [J]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2017, 52(2): 93-98.

    [9]

    Lou H, Meng Y, Piao Y, et al. Cellular phenotyping of chronic rhinosinusitis with nasal polyps[J]. Rhinology, 2016, 54(2): 150-159. doi: 10.4193/Rhino15.271

    [10]

    Wei B, Liu F, Zhang J, et al. Multivariate analysis of inflammatory endotypes in recurrent nasal polyposis in a Chinese population[J]. Rhinology, 2018, 56(3): 216-226. doi: 10.4193/Rhin17.240

    [11]

    Ramakrishnan VR, Hauser LJ, Feazel LM, et al. Sinus microbiota varies among chronic rhinosinusitis phenotypes and predicts surgical outcome[J]. J Allergy Clin Immunol, 2015, 136(2): 334-42.e1. doi: 10.1016/j.jaci.2015.02.008

    [12]

    Mahdavinia M, Engen PA, LoSavio PS, et al. The nasal microbiome in patients with chronic rhinosinusitis: Analyzing the effects of atopy and bacterial functional pathways in 111 patients[J]. J Allergy Clin Immunol, 2018, 142(1): 287-290.e4. doi: 10.1016/j.jaci.2018.01.033

    [13]

    Biswas K, Hoggard M, Jain R, et al. The nasal microbiota in health and disease: variation within and between subjects[J]. Front Microbiol, 2015, 9: 134.

    [14]

    Abreu NA, Nagalingam NA, Song Y, et al. Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis[J]. Sci Transl Med, 2012, 4(151): 151ra124.

    [15]

    Hoggard M, Biswas K, Zoing M, et al. Evidence of microbiota dysbiosis in chronic rhinosinusitis[J]. Int Forum Allergy Rhinol, 2017, 7(3): 230-239. doi: 10.1002/alr.21871

    [16]

    Ramakrishnan VR, Feazel LM, Gitomer SA, et al. The microbiome of the middle meatus in healthy adults[J]. PLoS One, 2013, 8(12): e85507. doi: 10.1371/journal.pone.0085507

    [17]

    Wagner Mackenzie B, Waite DW, Hoggard M, et al. Bacterial community collapse: a meta-analysis of the sinonasal microbiota in chronic rhinosinusitis[J]. Environ Microbiol, 2017, 19(1): 381-392. doi: 10.1111/1462-2920.13632

    [18]

    Hasegawa K, Linnemann RW, Mansbach JM, et al. Nasal Airway Microbiota Profile and Severe Bronchiolitis in Infants: A Case-control Study[J]. Pediatr Infect Dis J, 2017, 36(11): 1044-1051. doi: 10.1097/INF.0000000000001500

    [19]

    Biesbroek G, Tsivtsivadze E, Sanders EA, et al. Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children[J]. Am J Respir Crit Care Med, 2014, 190(11): 1283-1292. doi: 10.1164/rccm.201407-1240OC

    [20]

    Defoirdt T. Quorum-Sensing Systems as Targets for Antivirulence Therapy[J]. Trends Microbiol, 2018, 26(4): 313-328. doi: 10.1016/j.tim.2017.10.005

    [21]

    Hardy BL, Dickey SW, Plaut RD, et al. Corynebacterium pseudodiphtheriticum Exploits Staphylococcus aureus Virulence Components in a Novel Polymicrobial Defense Strategy[J]. mBio, 2019, 10(1): e02491-18

    [22]

    Ramsey MM, Freire MO, Gabrilska RA, et al. Staphylococcus aureus Shifts toward Commensalism in Response to Corynebacterium Species[J]. Front Microbiol, 2016, 7: 1230.

    [23]

    Kuhar HN, Tajudeen BA, Mahdavinia M, et al. Relative abundance of nasal microbiota in chronic rhinosinusitis by structured histopathology[J]. Int Forum Allergy Rhinol, 2018, 8(12): 1430-1437. doi: 10.1002/alr.22192

    [24]

    Choi EB, Hong SW, Kim DK, et al. Decreased diversity of nasal microbiota and their secreted extracellular vesicles in patients with chronic rhinosinusitis based on a metagenomic analysis[J]. Allergy, 2014, 69(4): 517-526. doi: 10.1111/all.12374

  • 加载中

(3)

(4)

计量
  • 文章访问数:  1686
  • PDF下载数:  505
  • 施引文献:  0
出版历程
收稿日期:  2020-03-04
刊出日期:  2020-09-05

目录